Skip to main content
. 2019 Aug 13;10(4):e01780-19. doi: 10.1128/mBio.01780-19

FIG 2.

FIG 2

ADAM9 plays a role in an early step in EMCV infection. (A) HAP1 clones were infected with dNGluc-EMCV or Rluc-CV-B3. Luminescence was measured at 6 h postinfection. Dashed lines indicate the WT signal (top) and the signal in the presence of a replication inhibitor (bottom). Values are means plus SEM (error bars) from two independent experiments. Values were compared to the WT values, and statistical significance was calculated by an unpaired two-sided t test. Values that are significantly different from the WT value are indicated as follows: ***, P < 0.001. Values that are not significantly different (ns) are indicated. (B) HAP1 clones were infected with dNGluc-EMCV in the presence of the replication inhibitor GPC-N114 (10 μM). Luminescence (in relative light units [RLU]) was measured at 6 h postinfection. Dashed lines indicate the WT signal (top) and the signal produced by uninfected cells (bottom). Values are means plus SEM (error bars) for three biological replicates. Statistical significance compared with the WT values were calculated by an unpaired two-sided t test of log-transformed data; ns, not significant; *, P < 0.05.